A study to determine the effect of Haritaki Churna and Navak Guggulu in the management of hyperlipidemia a randomized controlled trial - NI

Amol Ganeshdas Khatri0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年11月13日

研究概览

暂无简介。

•1. Age limit from 25 to 60 yrs.
•2. Patient irrespective of age, sex, religion etc. of hyperlipidemia.
•3. Obese and non-obese hyperlipidemic patients (BMI-18.50 to 40.00 kg/m2 as per New Updated WHO classification of BMI of 2004)
•4. Patients with controlled Type 2 diabetes mellitus ( Fasting < 130mg/dl Postmeal < 250mg/dl) , hypertension ( < 160/100mmHg) disorders.
•5. Patients with high blood lipid profile. Lipid profile showing any one or more of the following criteria was considered diagnostic of hyperlipidemia
•a. Patient having Serum Total Cholesterol Level >200mg/dl.
•b. Patient having Serum Triglycerides Level > 150 mg/dl.
•c. Patient having Serum LDL Cholesterol Level >130mg/dl.
•d. Patient having serum VLDL Cholesterol Level > 40 mg/dl.
•e. Patient having Serum HDL Cholesterol Level < 40 mg/dl.

•1. Patients having a history of untreated thyroid disorder.
•2. Pregnant women & lactating mother.
•3. Chronic illness and infection like TB, CA and HIV infection.
•4. Patient is suffering with psychological disorders like anxiety, depression.
•5. Patient with Respiratory Diseases Complications, Coronary Heart Disease, Hepatic or Renal Disease etc.
•6. Patients having drug induced hyperlipidemia like steroids.

发起方

Amol Ganeshdas Khatri